RobinNorrisMDMS, MPH

Pediatric Hematology & Oncology • Cincinnati, OH

Associate Professor, Cincinnati Children's Hospital Medical Center

Join to view full profile

Dr. Norris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Norris' full profile

Already have an account?

Office
3333 Burnet Ave
MLC#7018
Cincinnati, OH 45229
Phone+1 513-517-2067

Fax+1 513-636-3549

Education & Training

Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2005 - 2008
University of California (San Francisco)Residency, Pediatrics, 2001 - 2004
Perelman School of Medicine at the University of PennsylvaniaClass of 2001

Certifications & Licensure

CA State Medical License 2003 - Present
OH State Medical License 2012 - 2026
IN State Medical License 2022 - 2023
KY State Medical License 2021 - 2023
PA State Medical License 2005 - 2012
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

79 citations
Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Chi...
Rochelle Bagatell, Robin E. Norris, Ashish M. Ingle, Charlotte H. Ahern, Stephan D. Voss
Pediatric Blood & Cancer. 2014-05-01
36 citations
Challenges and opportunities in childhood cancer drug development.
Robin E. Norris, Peter C. Adamson
Nature Reviews. Cancer. 2012-11-01
24 citations
Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors.
Robin E. Norris, Suzanne Shusterman, Lia Gore, Jodi A. Muscal, Margaret E. Macy
Pediatric Blood & Cancer. 2014-10-01

Abstracts/Posters

V2 Trial: A Phase I Study of Venetoclax Combined with CPX-351 for Children, Adolescents and Young Adults with Relapsed or Refractory Acute Leukemia
Robin Norris, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Safety and Efficacy of Venetoclax in Combination with Navitoclax in Adult and Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Robin Norris, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

Old English, New TechnologyOctober 13th, 2017
66: Balancing Private Practice and ParentingMarch 17th, 2016